Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Nov 8, 2013, after the close
10-Q filed Nov 8, 2013, 39 days after period end · 0001171843-13-004541
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Revenue | $25.14M | $26.10M | $26.38M | $26.45M |
| Net Income | -$984.00K | -$133.00K | $28.00K | $12.73M |
| EPS Diluted | -$0.03 |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| -$0.01 |
| $0.00 |
| $0.44 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
